| Targeting innate immunity for neurodegenerative disorders of the central nervous system KI Andreasson, AD Bachstetter, M Colonna, F Ginhoux, C Holmes, ... Journal of neurochemistry 138 (5), 653-693, 2016 | 136 | 2016 |
| Vav, a GDP/GTP nucleotide exchange factor, interacts with GDIs, proteins that inhibit GDP/GTP dissociation M Groysman, CSN Russek, S Katzav FEBS letters 467 (1), 75-80, 2000 | 54 | 2000 |
| Dopaminergic neuronal cluster size is determined during early forebrain patterning N Russek-Blum, A Gutnick, H Nabel-Rosen, J Blechman, N Staudt, ... Oxford University Press for The Company of Biologists Limited 135 (20), 3401 …, 2008 | 51 | 2008 |
| Identification of the Drosophila melanogaster homologue of the mammalian signal transducer protein, Vav I Dekel, N Russek, T Jones, MA Mortin, S Katzav FEBS letters 472 (1), 99-104, 2000 | 31 | 2000 |
| High resolution fate map of the zebrafish diencephalon N Russek‐Blum, H Nabel‐Rosen, G Levkowitz Developmental Dynamics: An Official Publication of the American Association …, 2009 | 19 | 2009 |
| Efficacy of Ciprofloxacin/Celecoxib combination in zebrafish models of amyotrophic lateral sclerosis H Goldshtein, A Muhire, V Petel Legare, A Pushett, R Rotkopf, JM Shefner, ... Annals of Clinical and Translational Neurology 7 (10), 1883-1897, 2020 | 16 | 2020 |
| Two-photon-based photoactivation in live zebrafish embryos N Russek-Blum, H Nabel-Rosen, G Levkowitz JoVE (Journal of Visualized Experiments), e1902, 2010 | 8 | 2010 |
| A synthetic SOD/Catalase mimic compound for the treatment of ALS M Soll, H Goldshtein, R Rotkopf, N Russek-Blum, Z Gross Antioxidants 10 (6), 827, 2021 | 7 | 2021 |
| Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS S Salomon-Zimri, A Pushett, N Russek-Blum, RPA Van Eijk, N Birman, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24 (3-4), 263-271, 2023 | 5 | 2023 |
| Shifting the Paradigm-A Biomarker Driven Approach for Studying Amyotrophic Lateral Sclerosis (ALS) Therapy Activity S Zimri, N Kerem, N Russek-Blum, A Thompson, J Harris, J Xu, N Wong, ... MUSCLE & NERVE 68, S20-S20, 2023 | | 2023 |
| Shifting the Paradigm-PrimeC: A Potential DiseaseModifying Treatment for ALS Driven by Novel Biomarkers Measuring the Mechanism of Action S Zimri, F Tracik, N Russek-Blum, E Eitan, JD Berry, S Paganoni MUSCLE & NERVE 66, S13-S14, 2022 | | 2022 |
| Deciphering Developmental Processes that Determine the Size of Dopaminergic Neuronal Population N Russek-Blum Weizmann Institute of Science, 2009 | | 2009 |
